Aleksandra Rizo – Biography
Last update: February 23, 2026Executive profile
Aleksandra was Chief Medical Officer at Geron Corporation, and Executive Director, Strategy and Clinical Lead, Clinical R&D at Celgene. Aleksandra Rizo joined Bayer in 2024.
Aleksandra Rizo is currentlyChief Executive Officer and President at Vividion Therapeutics - View - Vividion Therapeutics org chart
Director at Syndax Pharmaceuticals - View - Syndax Pharmaceuticals org chart
Create your alert
to follow the career of Aleksandra Rizo.
Education
Aleksandra Rizo has a PhD from ksuniversiteit Groningen.
More about Aleksandra Rizo
Selected links
Do you need to know more about Aleksandra Rizo? More results.
Participate
Social media
- Aleksandra Rizo on Google News, X (Twitter), LinkedIn, YouTube
- View the pictures of Aleksandra Rizo
The colleagues of Aleksandra Rizo
Company Colleagues
- At Vividion Therapeutics, Aleksandra Rizo has 22 colleagues including Jeffrey Hatfield (Chairman of the Board), Olivier Mauroy-Bressier (Director)…
- At Syndax Pharmaceuticals, Aleksandra Rizo has 26 colleagues including Michael Metzger (CEO & Director), Jennifer Jarrett (Director)…
Industry Colleagues
- In the Biotechnology industry, Aleksandra Rizo has 35,756 colleagues in 2,406 companies located in 42 countries. 16,877 executive movements have been recorded in the last 12 months. Learn more about Biotechnology.
Report an error
Update the org chart details of Aleksandra Rizo.
Get in Touch
Here are a few tips for establishing great contacts.
and ask for Aleksandra Rizo.
